An Act relative to certain genetically targeted drug coverage for Duchenne Muscular Dystrophy
Substituted by the House, on motion of Mr. Speliotis of Danvers, for a bill with the same title (House, No. 3644). July 31, 2018.
Bill Information
Bill Information
- Sponsor:
- Theodore C. Speliotis
- Status:
- Referred to Senate Committee on Ways and Means
Bill History
Displaying 5 actions for Bill H.4865
| Date | Branch | Action |
|---|---|---|
| 7/31/2018 | House | Substituted for H3644 |
| 7/31/2018 | House | Ordered to a third reading |
| 7/31/2018 | House | Passed to be engrossed |
| 8/6/2018 | Senate | Read; and referred to the committee on Senate Ways and Means |
| 1/1/2019 | Senate | No further action taken |
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.